Upon TMZ treatment, Galectin signaling was linked to Lgals9 produced by myeloid cells predicted to interact with Cd44 in tumor cells and Ptprc (Cd45) in ependymal and myeloid cells. Here, LGALS9 is linked to neoplasm.